IFI30 and acute lymphoblastic leukemia: Not only that, at the level of individual cancer species, our study revealed that IFI30 did not demonstrate a robust correlation with immune cell infiltration in malignant tumors such as LAML, DLBC, ALL and UVM, and this specificity might afford a varied perspective for further studies on the utility of IFI30 in the immune microenvironment in the coming days.